STRUCTURE AFFINITY RELATIONSHIPS OF 12-SULFONYL DERIVATIVES OF 5,8,8A,9,10,11,12,12A,13,13A-DECAHYDRO-6H-ISOQUINO[2,1-G][1,6]NAPHTHYRIDINES AT ALPHA-ADRENOCEPTORS

被引:29
|
作者
CLARK, RD [1 ]
REPKE, DB [1 ]
BERGER, J [1 ]
NELSON, JT [1 ]
KILPATRICK, AT [1 ]
BROWN, CM [1 ]
MACKINNON, AC [1 ]
CLAGUE, RU [1 ]
SPEDDING, M [1 ]
机构
[1] SYNTEX RES CTR,DEPT PHARMACOL,EDINBURGH EH14 4AP,SCOTLAND
关键词
D O I
10.1021/jm00106a036
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Analogues of the potent alpha-2-adrenoceptor antagonist (8aR, 12aS, 13aS)-5,8,8a,9,10,11,12,12a,13, 13a-decahydro-3-methoxy-12-(methylsulfonyl)-6H-isoquino[2,1-g] [1,6]naphthyridine (1b) were prepared and evaluated for alpha-1- and alpha-2-adrenoceptor affinity. Affinity for alpha-2-adrenoceptors was assessed by displacement of [H-3]yohimbine from rat cerebral cortical membranes and although 1b and close structural analogues demonstrated high affinity, none were selective for the alpha-2A or alpha-2B subtypes reputedly present in this tissue. All of the high affinity alpha-2-adrenoceptor ligands were, however, selective with respect to [H-3]prazosin (alpha-1) binding. Affinity for [H-3]yohimbine-labeled alpha-2-adrenoceptors was found to be highly dependent on the stereochemistry of the tetracyclic system. The 8a-beta, 12a-alpha, 13a-alpha diastereomer of 1 (56) had moderate affinity for alpha-2-adrenoceptors while the 8a-beta, 12a-beta, 13a-alpha diastereomer (55) had very low affinity. The affinity and selectivity of these agents for alpha-2-adrenoceptors was found to correspond to that observed for several isomeric yohimbine analogues which have similar relative and absolute stereochemistries. Deviation from the structure of 1 by opening the B ring, changing the position of the sulfonamide nitrogen, or changing the attachment of the D ring led to a dramatic decrease in alpha-2-adrenoceptor affinity. High binding affinity was found to correlate with functional antagonism in the guinea pig ileum. The reversal of clonidine-induced mydriasis in the rat was used to assess bioavailability and indicated that 1b was a potent alpha-2-adrenoceptor antagonist in vivo.
引用
收藏
页码:705 / 717
页数:13
相关论文
共 24 条
  • [1] (8A-ALPHA,12A-ALPHA,13A-ALPHA)-5,8,8A,9,10,11,12,12A,13,13A-DECAHYDRO-3-METHOXY-12-(METHYLSULFONYL)-6H-ISOQUINO[2,1-G][1,6]NAPHTHYRIDINE, A POTENT AND HIGHLY SELECTIVE ALPHA2-ADRENOCEPTOR ANTAGONIST
    CLARK, RD
    REPKE, DB
    KILPATRICK, AT
    BROWN, CM
    MACKINNON, AC
    CLAGUE, RU
    SPEDDING, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (09) : 2034 - 2036
  • [2] The crystal structure of 4a-formyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydro-1-2-6a,6b,9,9,12a-heptamethylpicen-10-yl acetate, C32H50O3
    Latolla, Nehemiah
    Hosten, Eric C.
    Hlangothi, Buyiswa G.
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (05): : 1213 - 1215
  • [3] cis-3-methyl-1-phenyl-8a,9,10,11,12,12a,12b-hexahydro-1H,3bH-pyrazolo[3,4:2′,3′]pyrano[4′,5′,6′-kl] xanthene
    Kamala, E. Theboral Sugi
    Nirmala, S.
    Sudha, L.
    Ramesh, E.
    Raghunathan, R.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O245 - U4798
  • [4] The crystal structure of (6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-10-(4-acetoxy-3-methylbutyl)-6a,8a,9-trimethyl-3,4,5,6,6a,6b,7,8,8a,8b,9,10, 11a,12,12a,12b-hexadecahydro-1H-naphtho[2′,1′:4,5]indeno[2,1-b]furan-4-yl acetate, C31H48O5
    Mou, Xiao-Dong
    Wang, Hui-Yun
    Sun, Ke-Wei
    Luan, Ming-Zhu
    Meng, Qing-Guo
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (05): : 1223 - 1225
  • [5] Crystal structure of (4aR,6aR,6bR,10S,12aR)-10-acetoxy-1,2,3,4, 4a,5,6, 6a,6b,7,8,8a,9,10,11,12,12a, 12b,13,14b-icosahydro-2,2,4a,6b,9,9,12a-heptamethylpicene-6a-carboxylic acid, C32H50O4
    He, Kang
    Wu, Tian-Tai
    Shen, Lin-Yan
    Fan, Lin-Lin
    Ye, Jiang-Hai
    Zou, Juan
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2019, 234 (06): : 1261 - 1263
  • [6] Synthesis and crystal structure of ethyl (2S,4aS,6aS,6bR,8aR,12aS,12bR,14bR,E)-10-(((3,4-dichlorobenzyl)oxy)imino)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylate
    Dong, Zhang-Chao
    Shen, Hui
    Mu, Ze-Bo
    Xu, Kai-Hua
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2025, 240 (02): : 179 - 181
  • [7] Crystal structure of (5aS,6aS,8aR,9R,11aS, 11bS,13R,13aS)-1,1,8a,11a-tetramethyl-9-((S)-1-((S)-5-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-3-oxo-1,7,8,8a,9,10,11,11a,11b,12,13,13a-dodecahydro-3H,6H-cyclopenta[5,6]cyclopropa[1,8a]naphtho[2,1-c]oxepin-13-yl acetate, C32H44O6
    Jian, Cheng-Hong
    Chen, Ren-Song
    Zhang, Jie-Jing
    Zhao, Chen-Liang
    Zhao, Neng-Wu
    Ye, Jiang-Hai
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2024, 239 (01): : 117 - 120
  • [8] STRUCTURE OF (+/-)-6,TRANS-8B,9,10,11,12,13,TRANS-13A-OCTAHYDRO-5H-7-THIA-12A-AZABENZO[F]NAPHTH[1,2,3-CD]AZULENE
    MONGE, A
    GUTIERREZPUEBLA, E
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1981, 37 (FEB): : 465 - 468
  • [9] A New Terpenoid 3R, 4R, 4aR, 5R, 6aS, 6bR, 12aR)-4a (Hydroxyl methyl)-2,2,6a, 6b, 7,8,8a, 9,10,11,12,12a, 12b, 13,14b-Icosahydropicene, 3,4,5,10-tetraol from Scutellaria scandance
    Prasad, Dwarika
    Sati, S. P.
    ORIENTAL JOURNAL OF CHEMISTRY, 2011, 27 (04) : 1767 - 1770
  • [10] Crystal structure of 3,15a:8a,11-diepoxybenzo[4′,5′]cyclohept[1′,2′:4,5]-indeno[2,1b]oxepin-2-methanol-2,3,4,5,5a,5b,6,7,8,9,10,11,12,12a,13, 14,14b,15-octadecahydro-15-hydroxy-α,α,5,5b,12,12,14b-heptamethyl, C30H46O5, 24-epi-acerinol
    Liu, Yan-Ru
    Li, Chun-Tong
    Zhan, Qin
    Sun, Lian-Na
    Wu, Zhi-Jun
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2011, 226 (02): : 169 - 170